Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$846M |
| 2 |
JD.com
JD
|
+$782M |
| 3 |
Dollar General
DG
|
+$647M |
| 4 |
Monster Beverage
MNST
|
+$324M |
| 5 |
NXP Semiconductors
NXPI
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Union Pacific
UNP
|
+$668M |
| 2 |
Mondelez International
MDLZ
|
+$528M |
| 3 |
Alibaba
BABA
|
+$457M |
| 4 |
TWTR
Twitter, Inc.
TWTR
|
+$409M |
| 5 |
CELG
Celgene Corp
CELG
|
+$403M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.35% |
| 2 | Consumer Discretionary | 16.59% |
| 3 | Technology | 13.46% |
| 4 | Communication Services | 12.43% |
| 5 | Financials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNMK
426
DELISTED
GenMark Diagnostics, Inc
GNMK
| $27.3M | 0.03% |
3,009,825
-669,492
| -18% | -$6.75M |
|
|
TFM
427
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $26.7M | 0.02% |
830,567
+17,743
| +2% | +$621K |
|
428
Q2 Holdings
QTWO
$3.75B
| $26.5M | 0.02% |
936,729
+284,467
| +44% | +$6.65M |
|
429
Provident Financial Services
PFS
$3.04B
| $26.4M | 0.02% |
1,391,719
+83,028
| +6% | +$1.54M |
|
|
PPO
430
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
| $26.1M | 0.02% |
436,496
-175,781
| -29% | -$10.4M |
|
431
B2Gold
BTG
$6.9B
| $25.8M | 0.02% |
16,860,213
+398,296
| +2% | +$646K |
|
|
RDC
432
DELISTED
Rowan Companies Plc
RDC
| $25.8M | 0.02% |
1,219,879
+1,857
| +0.2% | +$39.3K |
|
433
Flotek Industries
FTK
$977M
| $25.7M | 0.02% |
341,582
+7,911
| +2% | +$640K |
|
|
MDCO
434
DELISTED
Medicines Co
MDCO
| $25.5M | 0.02% |
892,288
+8,978
| +1% | +$250K |
|
435
Lowe's Companies
LOW
$109B
| $25.2M | 0.02% |
376,759
+1,887
| +0.5% | +$135K |
|
|
EQM
436
DELISTED
EQM Midstream Partners, LP
EQM
| $25.1M | 0.02% |
308,375
-299,715
| -49% | -$24.9M |
|
437
Monolithic Power Systems
MPWR
$56.1B
| $25M | 0.02% |
492,826
+7,545
| +2% | +$399K |
|
|
HAPN
438
Happen Inc
HAPN
$1.89B
| $24.4M | 0.02% |
330,240
-235,330
| -42% | -$21M |
|
|
DYN.PRA
439
DELISTED
Dynegy Inc.
DYN.PRA
| $24.3M | 0.02% |
244,353
+322
| +0.1% | +$35.4K |
|
|
ICD
440
DELISTED
Independence Contract Drilling, Inc.
ICD
| $23.8M | 0.02% |
134,058
+2,874
| +2% | +$450K |
|
441
Plains GP Holdings
PAGP
$5.51B
| $23.6M | 0.02% |
342,719
+13,823
| +4% | +$1.04M |
|
|
HMHC
442
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $23.6M | 0.02% |
935,192
+20,088
| +2% | +$498K |
|
443
CALL
Tenet Healthcare
THC
$21B
| $23.2M | 0.02% |
+400,000
| New | +$20.4M |
|
444
Marcus & Millichap
MMI
$1.17B
| $23M | 0.02% |
497,656
+7,858
| +2% | +$335K |
|
|
FIT
445
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $22.7M | 0.02% |
+594,748
| New | +$20.9M |
|
|
KDNY
446
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $22.3M | 0.02% |
+149,980
| New | +$24.8M |
|
|
AFMD
447
DELISTED
Affimed
AFMD
| $22.2M | 0.02% |
+164,797
| New | +$15.8M |
|
448
Louisiana-Pacific
LPX
$4.53B
| $22M | 0.02% |
+1,291,408
| New | +$21.9M |
|
449
Trimble
TRMB
$13.7B
| $21.8M | 0.02% |
+930,497
| New | +$22.7M |
|
450
Kosmos Energy
KOS
$1.84B
| $21.7M | 0.02% |
2,579,482
+58,792
| +2% | +$523K |
|
Similar funds
Jennison Associates's Q2 2015 Portfolio in Review
As of Q2 2015, Jennison Associates held 801 positions worth $109B, down 0.05% from $109B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Jennison Associates's Q2 2015 filing shows 92 new, 315 increased, 305 reduced and 72 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M. The largest sale was Union Pacific, an estimated $668M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q2 2015 buy was Regeneron Pharmaceuticals: 1,732,726 shares worth $884M.
- Jennison Associates added most to JD.com in Q2 2015, an estimated $782M increase.
- Jennison Associates's biggest Q2 2015 reduction was Union Pacific, cutting an estimated $668M.
- Jennison Associates fully exited Perrigo in Q2 2015, selling an estimated $204M.
- Jennison Associates's ten largest holdings make up 21% of its $109B portfolio in Q2 2015.
- Jennison Associates opened 92 new positions and closed 72 in Q2 2015.
- Jennison Associates's portfolio value fell 0.05% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2015, filed 3 Aug 2015.